893 related articles for article (PubMed ID: 29409822)
1. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
2. Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease.
Zelber-Sagi S; Salomone F; Kolodkin-Gal I; Erez N; Buch A; Yeshua H; Webb M; Halpern Z; Shibolet O
Dig Liver Dis; 2017 May; 49(5):523-529. PubMed ID: 28179090
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study.
Bijnen M; van Greevenbroek MMJ; van der Kallen CJH; Scheijen JL; van de Waarenburg MPH; Stehouwer CDA; Wouters K; Schalkwijk CG
J Diabetes Res; 2019; 2019():6289831. PubMed ID: 31218233
[TBL] [Abstract][Full Text] [Related]
4. Association between the soluble receptor for advanced glycation end products (sRAGE) and NAFLD in participants in the Atherosclerosis Risk in Communities Study.
Laudenslager M; Lazo M; Wang D; Selvin E; Chen PH; Pankow JS; Clark JM
Dig Liver Dis; 2021 Jul; 53(7):873-878. PubMed ID: 33640303
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
[TBL] [Abstract][Full Text] [Related]
6. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products and their receptors did not show any association with body mass parameters in metabolically healthy adolescents.
Garay-Sevilla ME; Torres-Graciano S; Villegas-Rodríguez ME; Rivera-Cisneros AE; Wrobel K; Uribarri J
Acta Paediatr; 2018 Dec; 107(12):2146-2151. PubMed ID: 29846968
[TBL] [Abstract][Full Text] [Related]
8. Serum Soluble Receptor for AGE (sRAGE) Levels Are Associated With Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease.
Ivancovsky-Wajcman D; Zelber-Sagi S; Fliss Isakov N; Webb M; Zemel M; Shibolet O; Kariv R
Clin Transl Gastroenterol; 2019 May; 10(5):1-10. PubMed ID: 31082855
[TBL] [Abstract][Full Text] [Related]
9. Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs.
Bridglalsingh S; Archer-Hartmann S; Azadi P; Barbier de La Serre C; Remillard RL; Sunvold GD; Bartges JW
J Anim Physiol Anim Nutr (Berl); 2024 May; 108(3):735-751. PubMed ID: 38279966
[TBL] [Abstract][Full Text] [Related]
10. AGE-RAGE Interaction Does Not Explain the Clinical Improvements after Therapeutic Fasting in Osteoarthritis.
Drinda S; Franke S; Schmidt S; Stoy K; Lehmann T; Wolf G; Neumann T
Complement Med Res; 2018; 25(3):167-172. PubMed ID: 29433120
[TBL] [Abstract][Full Text] [Related]
11. Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis.
Machahua C; Montes-Worboys A; Planas-Cerezales L; Buendia-Flores R; Molina-Molina M; Vicens-Zygmunt V
Respir Res; 2018 Nov; 19(1):215. PubMed ID: 30409203
[TBL] [Abstract][Full Text] [Related]
12. Serum AGEs and sRAGE levels are not related to vascular complications in patients with prediabetes.
Gateva AT; Assyov YS; Tsakova AD; Kamenov ZA
Diabetes Metab Syndr; 2019; 13(2):1005-1010. PubMed ID: 31336435
[TBL] [Abstract][Full Text] [Related]
13. Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE).
Nowak A; Przywara-Chowaniec B; Damasiewicz-Bodzek A; Blachut D; Nowalany-Kozielska E; Tyrpień-Golder K
Cells; 2021 Dec; 10(12):. PubMed ID: 34944030
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer.
Jiao L; Taylor PR; Weinstein SJ; Graubard BI; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1430-8. PubMed ID: 21527578
[TBL] [Abstract][Full Text] [Related]
15. Relationship between serum-soluble receptor for advanced glycation end products (sRAGE) and disease activity in rheumatoid arthritis patients.
Jafari Nakhjavani MR; Jafarpour M; Ghorbanihaghjo A; Abedi Azar S; Malek Mahdavi A
Mod Rheumatol; 2019 Nov; 29(6):943-948. PubMed ID: 30474471
[No Abstract] [Full Text] [Related]
16. Changes in circulating levels of carboxymethyllysine, soluble receptor for advanced glycation end products (sRAGE), and inflammation markers in women during normal pregnancy.
Quintanilla-García CV; Uribarri J; Fajardo-Araujo ME; Barrientos-Romero JJ; Romero-Gutiérrez G; Reynaga-Ornelas MG; Garay-Sevilla ME
J Matern Fetal Neonatal Med; 2019 Dec; 32(24):4102-4107. PubMed ID: 29804482
[No Abstract] [Full Text] [Related]
17. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.
Paradela-Dobarro B; Agra RM; Álvarez L; Varela-Román A; García-Acuña JM; González-Juanatey JR; Álvarez E; García-Seara FJ
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1050-1060. PubMed ID: 31371263
[TBL] [Abstract][Full Text] [Related]
18. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
[TBL] [Abstract][Full Text] [Related]
19. Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
Prasad K
Mol Cell Biochem; 2019 Jan; 451(1-2):139-144. PubMed ID: 29961210
[TBL] [Abstract][Full Text] [Related]
20. Higher hepatic advanced glycation end products and liver damage markers are associated with nonalcoholic steatohepatitis.
Priken K; Tapia G; Cadagan C; Quezada N; Torres J; D'Espessailles A; Pettinelli P
Nutr Res; 2022 Aug; 104():71-81. PubMed ID: 35635899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
